INDEGENE LIMITED
- Minimum Investment₹14,190
- Price Range₹430 - ₹452
- Issue Size₹1,841.76 Cr
- Lot Size33 shares
Proceeds of this IPO to be used for
Repayment/prepayment of indebtedness of one of the material subsidiaries, ILSL Holdings.
Funding the capital expenditure requirements of the company and one of its material subsidiaries.
General corporate purposes and inorganic growth.
Strengths & Weaknesses of INDEGENE LIMITED
Domain expertise
The company's deep understanding of the healthcare domain enables it to efficiently modernize and digitize key functions involved in the life sciences commercialization process
Robust digital capabilities
The company has developed a suite of proprietary tools and platforms that include applications designed to automate processes and create AI-based efficiencies. These applications leverage AI, machine learning (ML), natural language processing (NLP), and advanced analytics capabilities, which are core components of the solutions offered
Long-standing client relationships
The company has long-standing relationships with marquee biopharmaceutical companies, including each of the 20 largest biopharmaceutical companies in the world by revenue for FY23
Global delivery model
The company caters to the needs of its clients from six operation hubs and 17 offices located across North America, Europe, and Asia
Dependent on subsidiaries
The majority of the company's revenues are derived from its subsidiaries. Therefore, any disruptions in the operations of one or more of its subsidiaries could adversely affect the business, financial condition, and results of operations
Sales efforts
The company's sales efforts involve considerable time and expense, and there is a risk that the revenues generated may not justify the expenses incurred towards these sales efforts
Outstanding legal proceedings
There are outstanding legal proceedings involving the company, its subsidiaries, and directors. Any adverse decision in these proceedings could adversely affect the business and results of operations
Contingent liabilities
The company has certain contingent liabilities and commitments that, if realized, may adversely affect its financial condition
Financials
Earnings Per Share
No Data
Balance Sheet
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Total Current Assets | -- | |
Total Non-Current Assets | -- | |
Fixed assets | -- | |
Total assets | -- | |
Total Current Liabilities | -- | |
Total Non-Current Liabilities | -- | |
Total Capital Plus Liabilities | -- | |
Total Shareholder Funds | -- | |
Total Debt to Equity | -- |
Cash Flow
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Cash from Operating Activity | -- | |
Cash from Financing Activities | -- | |
Cash from Investing Activities | -- | |
Net Cash Flow | -- |